CellCura ASA (FRA:C6L) EV-to-FCF : -0.12 (As of Jun. 04, 2024)

CellCura ASA EV-to-FCF Chart

CellCura ASA Quarterly Data
	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14
EV-to-FCF	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of CellCura ASA's EV-to-FCF

For the Biotechnology subindustry, CellCura ASA's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CellCura ASA's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CellCura ASA's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where CellCura ASA's EV-to-FCF falls into.

CellCura ASA EV-to-FCF Calculation

CellCura ASA's EV-to-FCF for today is calculated as:

CellCura ASA's current Enterprise Value is €0.13 Mil.
CellCura ASA's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2014 adds up the quarterly data reported by the company within the most recent 12 months, which was €-1.09 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CellCura ASA  (FRA:C6L) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

CellCura ASA's PE Ratio for today is calculated as:

CellCura ASA's share price for today is €0.02.
CellCura ASA's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2014 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.398.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.

CellCura ASA EV-to-FCF Related Terms

Thank you for viewing the detailed overview of CellCura ASA's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.

CellCura ASA (FRA:C6L) Business Description